Skip to main content

Blood Cancers and Research Progress

Blood Cancers and Research Progress

LLS has invested nearly $1.3 billion in cancer research since our founding in 1949, leading to nearly every advancement in blood cancer treatment and breakthroughs in immunotherapy, genomics and personalized medicine.

Our support of pioneering research at nearly 100 medical institutions worldwide is breaking new ground in the fight against cancer.

2020 Research Investment

Image source: the LLS Annual Report